There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

An X-ray can help healthcare professionals find non-small cell lung cancer tumors and gain a deeper understanding of them. The healthcare team will also need other imaging and tests for a complete ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care ...

Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test ...

World Lung Day is an annual campaign observed on September 25th to raise awareness about lung health and promote better lung care around the world. As we age, our lungs, like many other organs, ...

BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced that WPS Government Health Administrators, ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Study by BAMC ...

Study by BAMC’s Michael Morris, M.D., and VA’s Sheila Habib, M.D., evaluated potential economic impact of CyPath® Lung for the early detection of lung cancer “Our study suggests the potential for a ...